Academic Journal

Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial

التفاصيل البيبلوغرافية
العنوان: Immunotherapy with FBTA05 (Bi20), a trifunctional bispecific anti-CD3 x anti-CD20 antibody and donor lymphocyte infusion (DLI) in relapsed or refractory B-cell lymphoma after allogeneic stem cell transplantation: study protocol of an investigator-driven, open-label, non-randomized, uncontrolled, dose-escalating Phase I/II-trial
المؤلفون: Buhmann, Raymund, Michael, Stanglmaier, Juergen, Hess, Horst, Lindhofer, Peschel, Christian, Kolb, Hans-Jochem
بيانات النشر: Springer Nature
سنة النشر: 2013
المجموعة: Munich University of Technology (TUM): mediaTUM
مصطلحات موضوعية: info:eu-repo/classification/ddc
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: unknown
Relation: https://mediatum.ub.tum.de/1510513; https://mediatum.ub.tum.de/doc/1510513/document.pdf
DOI: 10.1186/1479-5876-11-160
الاتاحة: https://mediatum.ub.tum.de/1510513
https://mediatum.ub.tum.de/doc/1510513/document.pdf
https://doi.org/10.1186/1479-5876-11-160
Rights: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.7D29E2AF
قاعدة البيانات: BASE
الوصف
DOI:10.1186/1479-5876-11-160